These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6128382)

  • 21. [Extraneous particle contamination in injectable solutions. Proposed Italian standard].
    Caramella C; Montanari L; Pavanetto F; Ponci R
    Farmaco Prat; 1981 Mar; 36(3):148-61. PubMed ID: 7215535
    [No Abstract]   [Full Text] [Related]  

  • 22. Particulate inspection of parenteral products: from biophysics to automation.
    Knapp JZ; Kushner HK
    J Parenter Sci Technol; 1982; 36(3):121-7. PubMed ID: 7097455
    [No Abstract]   [Full Text] [Related]  

  • 23. Prediction of drug particle size and content uniformity in low-dose solid dosage forms.
    Huang CY; Sherry Ku M
    Int J Pharm; 2010 Jan; 383(1-2):70-80. PubMed ID: 19747967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters.
    Zarour-Shalev EH; Ovadia Y; Tuchmay O; Reynolds G; Lev N
    PDA J Pharm Sci Technol; 2015; 69(6):669-76. PubMed ID: 26659100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cleaning Validation: Complete Guide for Health - Based Approach in Chemical Cross - Contamination Risk Assessment.
    Tanyous JN
    PDA J Pharm Sci Technol; 2019; 73(2):204-210. PubMed ID: 30361288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Particulate Matter in Liquid-Finished Dosage Forms.
    Duchek J; Havasi B
    PDA J Pharm Sci Technol; 2018; 72(6):608-625. PubMed ID: 29853612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Charting and Evaluation of Environmental Microbial Monitoring Data.
    Bar R
    PDA J Pharm Sci Technol; 2015; 69(6):743-61. PubMed ID: 26659105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Particulate contamination in parenterals: current issues.
    Groves MJ
    Boll Chim Farm; 1991 Oct; 130(9):347-54. PubMed ID: 1799429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential hazard of particulate contamination of cardioplegic solutions.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extractables Screening of Polypropylene Resins Used in Pharmaceutical Packaging for Safety Hazards.
    Jenke D
    PDA J Pharm Sci Technol; 2017; 71(5):346-367. PubMed ID: 28512176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Particulate contamination in selected parenteral drugs.
    Longe RL
    Can Anaesth Soc J; 1980 Jan; 27(1):62-4. PubMed ID: 7353193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDA particulate matter panel discussion--an industry perspective.
    Hammer HF
    J Parenter Sci Technol; 1984; 38(5):170-2. PubMed ID: 6512655
    [No Abstract]   [Full Text] [Related]  

  • 35. A new coincidence model for single particle counters, Part I: Theory and experimental verification.
    Knapp JZ; Abramson LR
    J Pharm Sci Technol; 1994; 48(3):110-34. PubMed ID: 8069513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Particulate contamination--let's solve the problem.
    Bailey DE
    Am J Hosp Pharm; 1974 Jan; 31(1):30. PubMed ID: 4810163
    [No Abstract]   [Full Text] [Related]  

  • 37. Method for determination and element analysis of particulate contamination in injectable solutions.
    Winding O; Holma B
    Am J Hosp Pharm; 1976 Nov; 33(11):1154-9. PubMed ID: 998621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inorganic particle content of foods and drugs.
    Eisenberg WV
    Environ Health Perspect; 1974 Dec; 9():183-91. PubMed ID: 4377870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Industry perspective on the medical risk of visible particles in injectable drug products.
    Bukofzer S; Ayres J; Chavez A; Devera M; Miller J; Ross D; Shabushnig J; Vargo S; Watson H; Watson R
    PDA J Pharm Sci Technol; 2015; 69(1):123-39. PubMed ID: 25691720
    [No Abstract]   [Full Text] [Related]  

  • 40. Quality concept of parenterals in Europe.
    Möller H
    PDA J Pharm Sci Technol; 1995; 49(4):196-201. PubMed ID: 7552241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.